Evaluation CAPES Module #1: Juvenile Spondyloarthritis (JSpA) and Juvenile Psoriatic Arthritis (JPsA)

Demographic Questions

Question Title

* 1. Please provide your name and email address.

Name

Email Address

Question Title

* 2. What is your specialty?

Dermatology

Rheumatology

Primary Care

Other (please specify)

Question Title

* 3. Please indicate your practice setting.

Academic

Community

Question Title

* 4. Number of patients seen/impacted per week.

Activity Objectives: Please rate your level of achievement.

Question Title

* 5. Recognize a patient who may be presenting with a form of juvenile spondyloarthritis (JSpA).

Outstanding

Good

Average

Fair

Poor

Question Title

* 6. Describe the main clinical features of JSpA.

Outstanding

Good

Average

Fair

Poor

Question Title

* 7. Understand the current classification of JSpA.

Outstanding

Good

Average

Fair

Poor

Question Title

* 8. Recognize that this is an evolving area of pediatric rheumatology.

Outstanding

Good

Average

Fair

Poor

Question Title

* 9. To learn the age-related changes that make axial disease imaging challenging in youth.

Outstanding

Good

Average

Fair

Poor

Question Title

* 10. To learn mimics of axial inflammation in youth.

Outstanding

Good

Average

Fair

Poor

Question Title

* 11. To be familiar with treatment options for children with spondyloarthritis.

Outstanding

Good

Average

Fair

Poor

Question Title

* 12. To recognize long-term outcome of children with spondyloarthritis in comparison with children with other categories of JIA.

Outstanding

Good

Average

Fair

Poor

Evaluation of the Presenters

Question Title

* 13. The content of the presentation given by Aamena Hameed was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 14. The delivery of the presentation given by Aamena Hameed was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 15. Did Aamena Hameed appear objective and unbiased by commercial interests

Yes

If no, please explain:

Question Title

* 16. The content of the presentation given by Asad Khan was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 17. The delivery of the presentation given by Asad Khan was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 18. Did Asad Khan appear objective and unbiased by commercial interests

Yes

If no, please explain:

Question Title

* 19. The content of the presentation given by Wendy Olsder was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 20. The delivery of the presentation given by Wendy Olsder was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 21. Did Wendy Olsder appear objective and unbiased by commercial interests

Yes

If no, please explain:

Question Title

* 22. The content of the presentation given by Dax G. Rumsey, MD, MSc, FRCP(C), was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 23. The delivery of the presentation given by Dax G. Rumsey, MD, MSc, FRCP(C), was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 24. Did Dax G. Rumsey, MD, MSc, FRCP(C), appear objective and unbiased by commercial interests

Yes

If no, please explain:

Question Title

* 25. The content of the presentation given by Matthew Stoll, M.D., PhD, MSCS, FAAD, was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 26. The delivery of the presentation given by Matthew Stoll, M.D., PhD, MSCS, FAAD, was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 27. Did Matthew Stoll, M.D., PhD, MSCS, appear objective and unbiased by commercial interests

Yes

If no, please explain:

Question Title

* 28. The content of the presentation given by Pamela F. Weiss, MD, MSCE, was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 29. The delivery of the presentation given by Pamela F. Weiss, MD, MSCE, was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 30. Did Pamela F. Weiss, MD, MSCE, appear objective and unbiased by commercial interests

Yes

If no, please explain:

Question Title

* 31. As a moderator, Hema Srinivasalu, MD, was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 32. Did Hema Srinivasalu, MD, appear objective and unbiased by commercial interests

Yes

If no, please explain:

Relevance and Application

Question Title

* 33. Was the information in this activity relevant to your practice or professional development?

Yes

Question Title

* 34. I learned new information about JSpA and JPsA as a result of this program.

Yes

Question Title

* 35. Based on the information you received today, do you plan on changing your practice?

Yes, I intend to change the therapy that I render

Yes, I intend to alter the way that I evaluate my patients

Yes, I intend to change the legal/documentation/financial management of my practice

Yes, it may affect my patient referrals

No, but it did confirm my current practice

No, because it doesn’t directly apply to my practice

No, but it did increase my knowledge of community resources

No, because the information was inadequate and/or inaccurate

Other (please elaborate)

Question Title

* 36. How would you rate the presentation overall?

Outstanding

Good

Average

Fair

Poor

Evaluation CAPES Module #1: Juvenile Spondyloarthritis (JSpA) and Juvenile Psoriatic Arthritis (JPsA)

Question Title

* 1. Please provide your name and email address.

Question Title

* 2. What is your specialty?

Question Title

* 3. Please indicate your practice setting.

Question Title

* 4. Number of patients seen/impacted per week.

Question Title

* 5. Recognize a patient who may be presenting with a form of juvenile spondyloarthritis (JSpA).

Question Title

* 6. Describe the main clinical features of JSpA.

Question Title

* 7. Understand the current classification of JSpA.

Question Title

* 8. Recognize that this is an evolving area of pediatric rheumatology.

Question Title

* 9. To learn the age-related changes that make axial disease imaging challenging in youth.

Question Title

* 10. To learn mimics of axial inflammation in youth.

Question Title

* 11. To be familiar with treatment options for children with spondyloarthritis.

Question Title

* 12. To recognize long-term outcome of children with spondyloarthritis in comparison with children with other categories of JIA.

Question Title

* 13. The content of the presentation given by Aamena Hameed was:

Question Title

* 14. The delivery of the presentation given by Aamena Hameed was:

Question Title

* 15. Did Aamena Hameed appear objective and unbiased by commercial interests

Question Title

* 16. The content of the presentation given by Asad Khan was:

Question Title

* 17. The delivery of the presentation given by Asad Khan was:

Question Title

* 18. Did Asad Khan appear objective and unbiased by commercial interests

Question Title

* 19. The content of the presentation given by Wendy Olsder was:

Question Title

* 20. The delivery of the presentation given by Wendy Olsder was:

Question Title

* 21. Did Wendy Olsder appear objective and unbiased by commercial interests

Question Title

* 22. The content of the presentation given by Dax G. Rumsey, MD, MSc, FRCP(C), was:

Question Title

* 23. The delivery of the presentation given by Dax G. Rumsey, MD, MSc, FRCP(C), was:

Question Title

* 24. Did Dax G. Rumsey, MD, MSc, FRCP(C), appear objective and unbiased by commercial interests

Question Title

* 25. The content of the presentation given by Matthew Stoll, M.D., PhD, MSCS, FAAD, was:

Question Title

* 26. The delivery of the presentation given by Matthew Stoll, M.D., PhD, MSCS, FAAD, was:

Question Title

* 27. Did Matthew Stoll, M.D., PhD, MSCS, appear objective and unbiased by commercial interests

Question Title

* 28. The content of the presentation given by Pamela F. Weiss, MD, MSCE, was:

Question Title

* 29. The delivery of the presentation given by Pamela F. Weiss, MD, MSCE, was:

Question Title

* 30. Did Pamela F. Weiss, MD, MSCE, appear objective and unbiased by commercial interests

Question Title

* 31. As a moderator, Hema Srinivasalu, MD, was:

Question Title

* 32. Did Hema Srinivasalu, MD, appear objective and unbiased by commercial interests

Question Title

* 33. Was the information in this activity relevant to your practice or professional development?

Question Title

* 34. I learned new information about JSpA and JPsA as a result of this program.

Question Title

* 35. Based on the information you received today, do you plan on changing your practice?

Question Title

* 36. How would you rate the presentation overall?

Question Title

* 37. Please let us know about any other comments you have: